Literature DB >> 12031921

Feasibility of a home care program in a pediatric hematology and oncology department. Results of the first year of activity at a single Institution.

Maurizio Miano1, Luca Manfredini, Alberto Garaventa, Sara Fieramosca, Rita Tanasini, Monica Leimer, Daniela Trucco, Rossella Rossi, Riccardo Haupt, Giorgio Dini.   

Abstract

BACKGROUND AND OBJECTIVES: Giannina Gaslini Children's Hospital (GGCH) is a tertiary care hospital with an average of 100 new cancer diagnoses made each year. In April 2000, following preliminary analysis of the potential benefits, and the results of a questionnaire filled in by the parents attending the out-patient clinic, a Home Care (HC) program was started. DESIGN AND METHODS: Children in stable, non-critical, clinical conditions requiring i.v. therapy, parenteral nutrition, transfusional support, blood examinations, and central venous catheter use training management, as well as terminally ill children needing palliative and support therapy were considered eligible for the program.
RESULTS: After one year of activity, 45 children, aged 1 month-19 years (median 3 years), requiring i.v. therapy and blood tests in 32 cases, central venous catheter use training in 5, and palliative care in 8, were treated at home. The median duration of assistance for each child was 19 days (range 1-172). An average of 4 patients per week were assisted for a total of 1,364 days. A total of 881 accesses at home replaced 551 and 330 out-patient and in-patient days of hospitalization, respectively. The average cost per patient given home care (2,936 E, range 150-20,700) resulted to be significantly lower than the average cost per patient hospitalized to undergo the same procedures (9,785E, range 350-96,750). INTERPRETATION AND
CONCLUSIONS: The opportunity to reduce the frequency and duration of hospitalization represents an incalculable advantage for these children and their families. This report shows that home care is a feasible kind of assistance for children suffering from cancer, and reduces costs as well.

Entities:  

Mesh:

Year:  2002        PMID: 12031921

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

1.  Home intravenous therapy: Accessibility for Canadian children and youth.

Authors:  Dl Moore; R Bortolussi
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

2.  Feasibility of integrated home/hospital physiotherapeutic support for children with cancer.

Authors:  Christian Savio; Alberto Garaventa; Marina Gremmo; Riccardo Camoriano; Luca Manfredini; Sara Fieramosca; Giorgio Dini; Maurizio Miano
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

3.  A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.

Authors:  Kristal Duncan; Edina Sinanovic
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

4.  Safety and family satisfaction of a home-delivered chemotherapy program for children with cancer.

Authors:  Lucia De Zen; Irene Del Rizzo; Luca Ronfani; Francesca Barbieri; Marco Rabusin; Roberto Dall'Amico; Egidio Barbi; Margherita Robazza
Journal:  Ital J Pediatr       Date:  2021-02-26       Impact factor: 2.638

5.  Emergency-department accesses in home care paediatric patients: Occurrence and risks of use in a six-year retrospective investigation in Northern Italy.

Authors:  Sara Campagna; Alberto Borraccino; Gianfranco Politano; Marco Dalmasso; Aldo Ravaglia; Valerio Dimonte; Maria Michela Gianino
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.